Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.080
+0.040 (3.85%)
Sep 17, 2026, 4:00 PM EDT - Market closed
Annovis Bio Stock Forecast
ANVS's stock price has decreased by -53.38% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 4 analysts polled by S&P Global, Annovis Bio stock has a consensus rating of "Strong Buy" and an average price target of $10.5. The average 1-year stock price forecast is 872.22% higher than the current stock price, while the lowest is $7.00 (+548.15%) and the highest is $17 (+1,474.07%).
Price Target: $10.5 (+872.22%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Annovis Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Buy Maintains $7 | Buy | Maintains | $7 | +548.15% | Sep 4, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $17 | Buy | Reiterates | $17 | +1,474.07% | Aug 19, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $8 | Buy | Maintains | $8 | +640.74% | Aug 18, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.45
from -1.40
EPS Next Year
-0.86
from -1.45
EPS and Forward PE are based on non-GAAP adjusted numbers.